Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Asian Stock Markets Start New Year Higher as Tech and AI Shares Drive Gains
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
South Korea Exports Hit Record High as Global Trade Momentum Builds
Federal Reserve Begins Treasury Bill Purchases to Stabilize Reserves and Money Markets
Neuralink Expands Brain Implant Trials with 12 Global Patients
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Wall Street Ends Mixed as Tech and Financial Stocks Weigh on Markets Amid Thin Holiday Trading
Oil Prices Slide in 2025 as Oversupply and Geopolitical Risks Shape Market Outlook
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



